# Endocardial Mapping With the CoreMap EP Mapping System

Study · id `cardio:ct-nct06529978` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06529978](<https://clinicaltrials.gov/study/NCT06529978>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06529978

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 245 participants.

## Technical summary

Registry record NCT06529978. Non-randomized; no masking; primary purpose treatment. Start 2024-07-25 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 245 participants (planned count; ClinicalTrials.gov record NCT06529978, source copy `cardio:ctgov-nct06529978-2026-07-14`, retrieved 2026-10-26)
- Started: 2024-07-25 (actual) (ClinicalTrials.gov record NCT06529978, source copy `cardio:ctgov-nct06529978-2026-07-14`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06529978, source copy `cardio:ctgov-nct06529978-2026-07-14`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT06529978, source copy `cardio:ctgov-nct06529978-2026-07-14`, retrieved 2026-10-26)
- Countries: United States; Czechia (ClinicalTrials.gov record NCT06529978, source copy `cardio:ctgov-nct06529978-2026-07-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06529978-2026-07-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Endocardial Mapping With the CoreMap EP Mapping System
- Acronym: INvENI
- Condition: Persistent Atrial Fibrillation
- Intervention (Device): CoreMap EP Mapping System Mapping
- Intervention (Device): CoreMap EP Mapping System Map-Guided Ablation
- Lead sponsor: CoreMap Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 6226b5dc8c4bdfa375bfda2dc586826edb9485eddd0081a2c16ad7c09c7222d8
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
